Genetic subtype-independent inhibition of human immunodeficiency virus type 1 replication by CC and CXC chemokines. - Wikidata - thesis-toulmin - TriplyDB

Genetic subtype-independent inhibition of human immunodeficiency virus type 1 replication by CC and CXC chemokines.

Genetic subtype-independent inhibition of human immunodeficiency virus type 1 replication by CC and CXC chemokines.

http://www.wikidata.org/entity/Q33782007

about

Variable sensitivity of CCR5-tropic human immunodeficiency virus type 1 isolates to inhibition by RANTES analogs HIV-1 escape from a small molecule, CCR5-specific entry inhibitor does not involve CXCR4 use Potent, broad-spectrum inhibition of human immunodeficiency virus type 1 by the CCR5 monoclonal antibody PRO 140 Patients infected with CRF07_BC have significantly lower viral loads than patients with HIV-1 subtype B: mechanism and impact on disease progression Differential effects of human immunodeficiency virus isolates on beta-chemokine and gamma interferon production and on cell proliferation.Identification of CXCR4 domains that support coreceptor and chemokine receptor functions Will multiple coreceptors need to be targeted by inhibitors of human immunodeficiency virus type 1 entry?Differential inhibition of human immunodeficiency virus type 1 fusion, gp120 binding, and CC-chemokine activity by monoclonal antibodies to CCR5 HIV-1 Transmission, Replication Fitness and Disease Progression.Evidence that antibody-mediated neutralization of human immunodeficiency virus type 1 by sera from infected individuals is independent of coreceptor usage Use of coreceptors other than CCR5 by non-syncytium-inducing adult and pediatric isolates of human immunodeficiency virus type 1 is rare in vitro Human immunodeficiency virus (HIV)-positive sera obtained shortly after seroconversion neutralize autologous HIV type 1 isolates on primary macrophages but not on lymphocytes.Simian immunodeficiency viruses of diverse origin can use CXCR4 as a coreceptor for entry into human cells Use of inhibitors to evaluate coreceptor usage by simian and simian/human immunodeficiency viruses and human immunodeficiency virus type 2 in primary cells.Expression and use of human immunodeficiency virus type 1 coreceptors by human alveolar macrophages CD40-Mediated induction of CD4 and CXCR4 on B lymphocytes correlates with restricted susceptibility to human immunodeficiency virus type 1 infection: potential role of B lymphocytes as a viral reservoir.A cell line-based neutralization assay for primary human immunodeficiency virus type 1 isolates that use either the CCR5 or the CXCR4 coreceptor.Virus isolates during acute and chronic human immunodeficiency virus type 1 infection show distinct patterns of sensitivity to entry inhibitors.Role of chemokine and cytokine polymorphisms in the progression of HIV-1 disease.Modulating influence on HIV/AIDS by interacting RANTES gene variants Hemofiltrate CC chemokine 1[9-74] causes effective internalization of CCR5 and is a potent inhibitor of R5-tropic human immunodeficiency virus type 1 strains in primary T cells and macrophages Human immunodeficiency virus type 1 fitness is a determining factor in viral rebound and set point in chronic infection.Interaction of the CC-chemokine RANTES with glycosaminoglycans activates a p44/p42 mitogen-activated protein kinase-dependent signaling pathway and enhances human immunodeficiency virus type 1 infectivity Increased CCR5 affinity and reduced CCR5/CD4 dependence of a neurovirulent primary human immunodeficiency virus type 1 isolate.CC chemokine receptor 5 (CCR5) desensitization: cycling receptors accumulate in the trans-Golgi network.Intrapatient alterations in the human immunodeficiency virus type 1 gp120 V1V2 and V3 regions differentially modulate coreceptor usage, virus inhibition by CC/CXC chemokines, soluble CD4, and the b12 and 2G12 monoclonal antibodies.The CCR5 and CXCR4 coreceptors are both used by human immunodeficiency virus type 1 primary isolates from subtype C.Two mechanisms for human immunodeficiency virus type 1 inhibition by N-terminal modifications of RANTES Analysis of the mechanism by which the small-molecule CCR5 antagonists SCH-351125 and SCH-350581 inhibit human immunodeficiency virus type 1 entry.Potent Anti-HIV Chemokine Analogs Direct Post-Endocytic Sorting of CCR5 Changes in the V3 region of gp120 contribute to unusually broad coreceptor usage of an HIV-1 isolate from a CCR5 Delta32 heterozygote.CCR5 susceptibility to ligand-mediated down-modulation differs between human T lymphocytes and myeloid cells.The LD78beta isoform of MIP-1alpha is the most potent CCR5 agonist and HIV-1-inhibiting chemokine.Env sequence determinants in CXCR4-using human immunodeficiency virus type-1 subtype C.Highly potent, fully recombinant anti-HIV chemokines: reengineering a low-cost microbicide.Platelet Factor 4 Inhibits and Enhances HIV-1 Infection in a Concentration-Dependent Manner by Modulating Viral Attachment Initiation of human immunodeficiency virus type 1 (HIV-1) transcription is inhibited by noncytolytic CD8 suppression Effective activation alleviates the replication block of CCR5-tropic HIV-1 in chimpanzee CD4+ lymphocytes.HIV-1 Nef induces CCL5 production in astrocytes through p38-MAPK and PI3K/Akt pathway and utilizes NF-kB, CEBP and AP-1 transcription factors.HIV-1 Entry, Inhibitors, and Resistance

P2860

Q28344169-DE5B96DD-D08C-41E6-B605-1551ACD6F383 Q28344746-BAA61590-B80E-4470-9160-0EB9C7267415 Q28345395-ECC72CCC-BBC8-4F82-8D74-33F23B9EBE4E Q28542678-28FA89B3-37B6-4DE5-AA66-9FFF511ADB9C Q33641854-E75C1458-C58B-47BD-9712-CEB017FD0E02 Q33643223-0EEDA97F-1584-4766-B3A8-1E8DE9F417C1 Q33645423-EE0025AA-3FE5-47F7-8A15-9452775C861E Q33647608-B7EEC67E-C873-4ADE-A990-BB729CD05ED8 Q33758570-D4BFD9FD-8EEF-4412-B06C-3C48E41F949B Q33782296-2AEF1E58-6D31-4B30-859E-0FDAD2A29A90 Q33785490-183CEDEF-733B-4FF7-B8FE-CACC472657BC Q33805324-5F6268E9-2C12-48BF-9A9B-126758598A1E Q33806017-76AADD8C-C3F9-447C-9F2D-31C025AA7375 Q33808728-59CB4440-A52E-437D-8BE4-79E971FAF455 Q33815704-F6624C63-B9E1-4759-99EF-10E48E596B0E Q33818747-54613F9A-8AB5-4193-A3B1-01225C6EDC71 Q33822395-8F18EEBD-E21E-4DEF-94EC-2979CC3295E3 Q33843345-71CA4A8E-7270-41DA-9CED-60415B84E6EE Q33964392-8DD38654-A6B7-4ED4-BDA7-2F84A6C66330 Q34098634-473E4029-2C8F-4022-9CAA-D15BE9AA0048 Q34106131-DD4A32B7-BD00-4D64-808B-9E88773C1D21 Q34227596-00CF8FD2-D73B-4980-99E9-9477E9A89D2C Q34332050-E94BF550-5C1D-45B1-BBE3-184A97A2156E Q34340428-D3C064FB-1D22-407D-9F54-C9CBBDFDEF9A Q34438951-045C0E69-6DED-48CF-8339-B204537AC197 Q34553676-6E036A0F-20C8-4A76-960B-97DB9247D649 Q34781878-E3CD7ADB-7E14-4103-9153-67F770943079 Q34823587-75ECBD07-4406-454A-B224-E3B2DCF49232 Q34975941-237C20B1-9C79-491A-AAFF-EA4ECEAB976E Q35617641-3772E51D-49E9-42F9-9574-A5751E775AD4 Q35985849-544CCF24-CEFE-4D14-A862-64CA475DCEDA Q36028163-16C0B820-2C44-482E-98BF-EF2E06159EA4 Q36736256-4BADE121-3A16-41AA-85BC-5770516C158D Q36740547-3E41F31F-7507-4DBC-B96F-34F8053D47D5 Q36976659-5D30879D-1371-42E7-A17B-EC82A835FCD9 Q37062259-EFF86E9A-E6C3-4A51-A33F-869FB021A464 Q37175151-B6C11AEB-FE47-4038-BAA3-3E437E45AAF3 Q37399694-17445F54-8F1B-4AE9-9FD6-6CD7901B3C74 Q37657314-694FE1B1-556E-4EFE-AADE-3F89324C5B3A Q37945205-7C4FEFC0-26F0-4E6E-A557-2A3D26B309BF

P2860

Genetic subtype-independent inhibition of human immunodeficiency virus type 1 replication by CC and CXC chemokines.

http://www.wikidata.org/entity/Q33782007

description

1998 nî lūn-bûn

@nan

1998 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

1998 թվականի հունվարին հրատարակված գիտական հոդված

@hy

1998年の論文

@ja

1998年論文

@yue

1998年論文

@zh-hant

1998年論文

@zh-hk

1998年論文

@zh-mo

1998年論文

@zh-tw

1998年论文

@wuu

name

Genetic subtype-independent in ...... tion by CC and CXC chemokines.

@ast

Genetic subtype-independent in ...... tion by CC and CXC chemokines.

@en

type

label

Genetic subtype-independent in ...... tion by CC and CXC chemokines.

@ast

Genetic subtype-independent in ...... tion by CC and CXC chemokines.

@en

prefLabel

Genetic subtype-independent in ...... tion by CC and CXC chemokines.

@ast

Genetic subtype-independent in ...... tion by CC and CXC chemokines.

@en

P1433

Q33782007-D2F06E46-8DB0-45B9-AE23-4386E8118994

P1476

Q33782007-C5143446-F4BF-40E2-B78B-CE3C49B218EA

P2093

Q33782007-0C06EFC4-7ADC-4F95-A750-A34990104DF6

Q33782007-0D12BBFC-F89C-4C23-9266-586D6C0D3E84

Q33782007-3ABBEBA2-83FA-4227-9B19-0C2DA725F2FC

Q33782007-3EC07839-2FA5-4BB8-8196-156BBD3EACCF

Q33782007-5133EA5A-5480-4560-87B6-83F33CDCC5F6

Q33782007-697EF0B6-6398-401E-8438-2F3C8AE375D9

Q33782007-7BA2AEBD-CC7F-4524-AEAA-3CFE34862ECF

Q33782007-CAA4EF3B-6048-4E32-BDCA-E977402D3FCE

Q33782007-EADBD00D-9A93-4B6D-8A93-F08C7E93C40A

P2860

Q33782007-07F68E98-CA8E-4947-B676-FD2620D425BA

Q33782007-0D91E81C-0353-4EA3-B755-A14347B4C443

Q33782007-11D1E9C0-F94B-4D08-8181-CEDEE88D71C9

Q33782007-1816B2D1-D8D5-401B-A1F7-DA9C032070AB

Q33782007-196B4D29-901D-40C1-A95E-523255B1C639

Q33782007-2F383AC7-DA68-4028-820D-ACFB88732B49

Q33782007-2FB98166-C474-4DB1-B97D-9C3EB10CA659

Q33782007-3B0E528D-8DF5-467E-BC93-1C5D562ECBAC

Q33782007-3B32300B-D3C7-46F7-9501-F84BFD84E4A4

Q33782007-3F377C2A-A520-4597-B430-00EBA048A892

P304

Q33782007-30D86841-FBD8-4EFB-87DE-F139C403B193

P31

Q33782007-A3E1EB93-C1FE-4CB6-AD7F-D90043C63C0E

P433

Q33782007-9D67EBD9-76D0-4A2C-96F8-EB668A64CE9A

P478

Q33782007-6CA52D32-F79A-4C4F-BCCB-327295CCA7D8

P50

Q33782007-DE43B3D4-658D-4BB6-B502-73268A17C009

P577

Q33782007-50DBDA76-3B5E-434D-A61A-DB3C1A513C63

P698

Q33782007-6C86173E-8BB7-45A8-99F1-C16C8C8861DF

P932

Q33782007-BB4D1CD7-963E-45E6-955C-677DEC77669A

P1433

Journal of Virology

P1476

Genetic subtype-independent in ...... ation by CC and CXC chemokines

@en

P2093

C R Mackay

http://www.w3.org/2001/XMLSchema#string

D A Thompson

http://www.w3.org/2001/XMLSchema#string

J A Hoxie

http://www.w3.org/2001/XMLSchema#string

J P Moore

http://www.w3.org/2001/XMLSchema#string

L Wu

http://www.w3.org/2001/XMLSchema#string

M A Siani

http://www.w3.org/2001/XMLSchema#string

R Horuk

http://www.w3.org/2001/XMLSchema#string

S P Monard

http://www.w3.org/2001/XMLSchema#string

W A Paxton

http://www.w3.org/2001/XMLSchema#string

P2860

Macrophages secrete a novel heparin-binding protein with inflammatory and neutrophil chemokinetic properties

HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor

Identification of a major co-receptor for primary isolates of HIV-1

Molecular cloning and functional expression of a new human CC-chemokine receptor gene

The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry

Expression cloning of new receptors used by simian and human immunodeficiency viruses

Molecular cloning and functional characterization of a novel human CC chemokine receptor (CCR5) for RANTES, MIP-1beta, and MIP-1alpha

STRL33, A novel chemokine receptor-like protein, functions as a fusion cofactor for both macrophage-tropic and T cell line-tropic HIV-1

Two orphan seven-transmembrane segment receptors which are expressed in CD4-positive cells support simian immunodeficiency virus infection

A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors

P304

396-404

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

72

http://www.w3.org/2001/XMLSchema#string

P50

Alexandra Trkola

P577

1998-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

9420238

http://www.w3.org/2001/XMLSchema#string

P932

109387

http://www.w3.org/2001/XMLSchema#string